Bank of America’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-58,381
Closed -$1.67M 7665
2018
Q4
$1.67M Buy
58,381
+38,315
+191% +$1.09M ﹤0.01% 4002
2018
Q3
$560K Sell
20,066
-28,368
-59% -$798K ﹤0.01% 4867
2018
Q2
$1.35M Buy
48,434
+15,028
+45% +$403K ﹤0.01% 4273
2018
Q1
$831K Sell
33,406
-173,927
-84% -$4.23M ﹤0.01% 4515
2017
Q4
$5.02M Buy
207,333
+199,116
+2,423% +$5.25M ﹤0.01% 3113
2017
Q3
$227K Sell
8,217
-182,667
-96% -$4.87M ﹤0.01% 5323
2017
Q2
$4.79M Sell
190,884
-20,563
-10% -$509K ﹤0.01% 3069
2017
Q1
$5.67M Buy
211,447
+147,887
+233% +$4.09M ﹤0.01% 2898
2016
Q4
$1.67M Sell
63,560
-6,116
-9% -$151K ﹤0.01% 3924
2016
Q3
$1.74M Buy
69,676
+35,754
+105% +$834K ﹤0.01% 3758
2016
Q2
$735K Sell
33,922
-2,816
-8% -$50.2K ﹤0.01% 4404
2016
Q1
$551K Sell
36,738
-11,604
-24% -$194K ﹤0.01% 4536
2015
Q4
$1.06M Sell
48,342
-40,658
-46% -$758K ﹤0.01% 4331
2015
Q3
$1.4M Buy
89,000
+57,598
+183% +$923K ﹤0.01% 4072
2015
Q2
$449K Buy
31,402
+24,194
+336% +$410K ﹤0.01% 4770
2015
Q1
$125K Sell
7,208
-4,874
-40% -$86.1K ﹤0.01% 5201
2014
Q4
$217K Sell
12,082
-6,304
-34% -$102K ﹤0.01% 5309
2014
Q3
$241K Buy
18,386
+6,983
+61% +$94K ﹤0.01% 5228
2014
Q2
$164K Buy
11,403
+9,189
+415% +$120K ﹤0.01% 5730
2014
Q1
$28K Sell
2,214
-34,021
-94% -$444K ﹤0.01% 6746
2013
Q4
$362K Buy
36,235
+14,704
+68% +$167K ﹤0.01% 5057
2013
Q3
$282K Sell
21,531
-14,077
-40% -$185K ﹤0.01% 5142
2013
Q2
$509K Buy
+35,608
New +$448K ﹤0.01% 4729

Other funds holding NXTM

Bank of America's NXTM Position: Q1 2019 in Review

Bank of America sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 58,381 shares — an estimated $1.67M sold.

Bank of America first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $5.67M in Q1 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Bank of America reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Bank of America sold 58,381 NxStage Medical Inc. shares in Q1 2019, an estimated $1.67M.
  • Bank of America first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Bank of America's NxStage Medical Inc. position peaked at $5.67M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Bank of America's 13F filing for Q1 2019, filed 15 May 2019.